Comparing surgery alone to surgery plus radiation for nasal and sinus cancer
Part of Cancer clinical trials.
This study compares surgery alone versus surgery followed by radiation therapy for a rare type of nasal or sinus cancer. It aims to see if adding radiation after surgery helps prevent the cancer from coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a specific rare type of nasal or sinus cancer (adenoid cystic carcinoma, cribriform or tubular type).
- You have already had surgery to remove the entire tumor, and the surgeon confirmed that no cancer was left behind (clear margins).
- The cancer is at an early to medium stage (T1, T2, or T3) and has not spread to lymph nodes or other organs.
- You are in generally good health (able to do daily activities and have adequate organ function).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining the targeted drug becotatug vedotin with chemo can shrink recurrent adenoid cystic sinus tumors that can't be fully removed by surgery. It's for people whose tumors have a specific protein called EGFR.
This study looks at whether surgery followed by radiation helps people with a specific type of sinus cancer called adenoid cystic carcinoma that has grown into nearby tissues. It aims to see how well this treatment works and how safe it is.
This trial tests two medications given before surgery for advanced adenoid cystic carcinoma in the nose or sinuses. The goal is to shrink the tumor and make surgery safer and more effective.
This trial tests a combination of chemotherapy and a targeted drug called tazemetostat for a rare type of nasal cancer that has not spread. The goal is to see if this combination can shrink the tumor and improve outcomes.
This trial compares standard radiation to radiation plus chemotherapy after surgery for early-stage cervical cancer. It aims to lower the chance the cancer comes back in patients considered higher risk based on their surgical pathology.
This trial compares giving chemotherapy and immunotherapy before surgery (neoadjuvant) versus after surgery (adjuvant) for patients whose nasopharyngeal cancer has returned locally. It aims to find which approach works better to control the cancer.
Hear when a new Adenoid Cystic Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.